CTSW has recently represented a New Jersey-based pharmaceutical subsidiary of an international healthcare products corporation in the acquisitions of rights to sell pharmaceutical products. In one transaction, the company acquired these rights as a result of an FTC-mandated divestiture. The transactions are the latest in CTSW’s long history of work for pharmaceutical and life sciences companies in product acquisitions and divestitures, licensing, development, manufacturing, supply, and distribution agreements, clinical trials agreements, corporate structure and governance matters, patents, litigation, and other areas.